🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

2 Capsule(s) Serving Size
60 Servings
Other Combinations Product Type
50% Evidence Coverage

Supplement Facts — Evidence Check

N-Acetyl-L-Cysteine
300 mg
250 mg
📊 Market median: 500.0mg (283 products) 📚 173 studies (Tier A: 0, B: 62)
This product: 250mg
Perilla Seed Extract
150 mg
📊 Market median: 470.0mg (230 products) 📚 9 studies (Tier A: 3, B: 3)
This product: 160mg

Other Ingredients

Cellulose Water Cellulose

Label Claims — Verification

All Other
Structure/Function
All Other (100% of products) Structure/Function (81% of products) Nutrient (3% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free

Product Information

📋 Directions for Use

Recommendations: As a dietary supplement, take 2 capsules, 1-2 times daily, between meals or as directed by a health professional.

⚠️ Warnings & Precautions

Warning: If you are pregnant or lactating, have any health condition or are taking any medication, consult your health professional before use.

Keep out of the reach of children.

Use only if safety seal is intact.

🧪 Formulation Notes

Certified Gluten-Free by the Gluten-Free Certified Organization www.gluten.org Gluten-Free, Non-GMO & Hypoallergenic

PureResponse Formula: Helps to modulate the Th2 immune response and maintain Th1/Th2 balance at the cellular level. Gluten-Free, Non-GMO & Hypoallergenic

Additional Information

Store in a cool, dry place.

Contents may not fill package in order to accommodate required labeling. Please rely on stated quantity. Scan to learn about our hypoallergenic supplements

GFCO.org (Gluten-Free Certification Organization)

Product Details

UPC / SKU 7 66298 02203 1
DSLD Entry Date 2023-12-14
Product Type Other Combinations
Form Capsule
DSLD ID 299740
Data Updated 2026-04-11

Research Evidence

9 Research Sources
60 Avg Quality Score
5 Meta Analysis
2 Cochrane Review
1 Systematic Review
1 Rct
B Astragalus (a traditional Chinese medicine) for treating chronic kidney disease.
Cochrane Review The Cochrane database of systematic reviews
B Oral Astragalus (Huang qi) for preventing frequent episodes of acute respiratory tract infection in children.
Cochrane Review The Cochrane database of systematic reviews
B Evaluating traditional Chinese medicine (TCM) Jie Geng and Huang Qi combination on reducing surgical site infections in colorectal cancer surgeries: A systematic review and meta-analysis
Meta Analysis International wound journal 2024
B Chronic fatigue syndrome post-COVID-19: triple-blind randomised clinical trial of Astragalus root extract
Rct BMJ supportive & palliative care 2025
B Efficacy and potential pharmacological mechanism of Astragalus-Salvia miltiorrhiza combination in diabetic nephropathy: integrating meta-analysis, network pharmacology, molecular docking, and experimental validation
Meta Analysis Renal failure 2025
B Renal protective effects and mechanisms of Astragalus membranaceus for diabetic kidney disease in animal models: An updated systematic review and meta-analysis
Meta Analysis Phytomedicine : international journal of phytotherapy and phytopharmacology 2024
C Adjuvant therapy with Astragalus membranaceus for post-stroke fatigue: a systematic review
Systematic Review Metabolic brain disease 2020
C Efficacy of Astragalus Membranaceus (Huang Qi) for Cancer-Related Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Studies
Meta Analysis Integrative cancer therapies 2025
C The Effect of Astragalus on Humoral and Cellular Immune Response: A Systematic Review and Meta-Analysis of Human Studies
Meta Analysis Complementary medicine research 2023
View all evidence for Astragalus →

Compare Similar Products

View all Astragalus products →